[144] First BanCorp. SEC Filing
Rhea-AI Filing Summary
First BanCorp (FBP) filing a Form 144 notifies a proposed sale of 50,000 shares of First BanCorp common stock through Merrill Lynch on or about 08/22/2025, with an aggregate market value of $1,100,000.00. The filing records that these shares were originally acquired as restricted stock granted as compensation: 40,240 shares on 03/31/2024 and 9,760 shares on 03/18/2022. The filer also reported a prior sale on 06/11/2025 of 22,871 shares for gross proceeds of $467,672.40. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.
Positive
- Planned sale disclosed with broker, sale date, and aggregate market value, improving market transparency
- Acquisition details provided showing shares were received as restricted stock on specific dates (03/31/2024 and 03/18/2022)
- Prior sale reported for 22,871 shares on 06/11/2025 with gross proceeds of $467,672.40, fulfilling three-month sales disclosure
Negative
- None.
Insights
TL;DR: Routine insider sale notice under Rule 144 for 50,000 shares; provides transaction dates and prior sales.
The Form 144 disclosure is procedural, documenting a planned sale of 50,000 First BanCorp shares via Merrill Lynch with stated acquisition dates and amounts tied to restricted stock compensation. It also records a recent sale of 22,871 shares generating $467,672.40. For investors, this filing supplies transparency about share disposals by an insider or person required to report under Rule 144. The filing contains no operational, earnings, or forward-looking information.
TL;DR: Compliance-focused filing that meets Rule 144 disclosure requirements; not a material corporate event.
The document meets statutory disclosure obligations by identifying the broker, sale date, share counts, acquisition method (restricted stock as compensation) and prior sales within three months. It includes the seller's certification regarding material information. There is no information here about board changes, governance actions, or regulatory matters; the filing should be viewed as a compliance notice rather than a corporate development.